These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 8937352)
21. Pathogenesis of pigment and spheroid formation in Hallervorden-Spatz syndrome and related disorders. Park BE; Netsky MG; Betsill WL Neurology; 1975 Dec; 25(12):1172-8. PubMed ID: 1238961 [TBL] [Abstract][Full Text] [Related]
22. Dominantly inherited, early-onset parkinsonism: neuropathology of a new form. Dwork AJ; Balmaceda C; Fazzini EA; MacCollin M; Côté L; Fahn S Neurology; 1993 Jan; 43(1):69-74. PubMed ID: 8423914 [TBL] [Abstract][Full Text] [Related]
23. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients. Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033 [TBL] [Abstract][Full Text] [Related]
24. How broad is the phenotype of Hallervorden-Spatz disease? Hickman SJ; Ward NS; Surtees RA; Stevens JM; Farmer SF Acta Neurol Scand; 2001 Mar; 103(3):201-3. PubMed ID: 11240570 [TBL] [Abstract][Full Text] [Related]
25. Magnetic resonance imaging in pathologically proven Hallervorden-Spatz disease. Schaffert DA; Johnsen SD; Johnson PC; Drayer BP Neurology; 1989 Mar; 39(3):440-2. PubMed ID: 2927660 [TBL] [Abstract][Full Text] [Related]
30. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Apaydin H; Ahlskog JE; Parisi JE; Boeve BF; Dickson DW Arch Neurol; 2002 Jan; 59(1):102-12. PubMed ID: 11790237 [TBL] [Abstract][Full Text] [Related]
31. Susceptibility Magnetic Resonance Imaging Correlates with Glial Density and Tau in the Substantia Nigra Pars Compacta. Wang EW; Brown GL; Lewis MM; Jellen LC; Pu C; Johnson ML; Chen H; Kong L; Du G; Huang X Mov Disord; 2023 Mar; 38(3):464-473. PubMed ID: 36598274 [TBL] [Abstract][Full Text] [Related]
32. Normal substantia nigra patients treated with levodopa - Clinical, therapeutic and pathological observations. Rajput AH; Rajput ML; Robinson CA; Rajput A Parkinsonism Relat Disord; 2015 Oct; 21(10):1232-7. PubMed ID: 26372624 [TBL] [Abstract][Full Text] [Related]
33. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study. Patt S; Gertz HJ; Gerhard L; Cervós-Navarro J Histol Histopathol; 1991 Jul; 6(3):373-80. PubMed ID: 1725760 [TBL] [Abstract][Full Text] [Related]
35. [A 65-year-old man with Parkinsonism, gaze palsy, and dementia]. Mizuno Y; Yokochi F; Ohta S; Mori H; Takubo H No To Shinkei; 1996 Apr; 48(4):381-93. PubMed ID: 8679336 [TBL] [Abstract][Full Text] [Related]
36. Amyotrophic lateral sclerosis with dementia showing clinical parkinsonism and severe degeneration of the substantia nigra: report of an autopsy case. Shintaku M; Oyanagi K; Kaneda D Neuropathology; 2007 Jun; 27(3):295-9. PubMed ID: 17645246 [TBL] [Abstract][Full Text] [Related]
37. [A case of Hallervorden-Spatz disease with magnetic resonance imaging data]. Ruiz-Sandoval JL; García-Ramos G; Vega-Boada F; Estañol-Vidal B Rev Invest Clin; 1998; 50(3):249-53. PubMed ID: 9763892 [TBL] [Abstract][Full Text] [Related]
38. Pure akinesia due to lewy body Parkinson's disease: a case with pathology. Quinn NP; Luthert P; Honavar M; Marsden CD Mov Disord; 1989; 4(1):85-9. PubMed ID: 2538728 [TBL] [Abstract][Full Text] [Related]